I am wondering. Have you sent your request directly to CYTR? Or better yet, have you contacted Dr. Katz or Dr. Levitt to see what they think of your idea?
Yeah he sure has people dazzled by him. But if he does not eventually turn a profit with TSLA, those shareholders will want to burn him at the stake eventually.
I think I understand your question. You are wondering what the quarter structure is for the quarterly payments? Is it Jan-Mar, Apri-June, etc. And when is the quarterly payment received by IPCI. Sorry, I do not have the answer. But ask this on ipci dot ca- someone there may know.
The only thing that looked to me like it was pushed back was Kaposi's. It is now by year end. I think it was previously 1H15 or 2H15 but can't remember.
Does anyone on here own TSLA? I find it crazy that they have never made a dime and their market cap is $28B! I really hope they have some technology that can be harnessed from everything they are doing, or they will one day disappoint shareholders in a major way.
They are doing great. I am OK with the dividend but would like to see them continue acquiring more pipeline. And yes, the ongoing trials are very important.
Quit your wining you little girl... I have never seen anything like the short term crybaby investors on YMB that that cry about every downward trend. Take some accountability for you DD and the investment you made. No one forced you to hit the buy button. And you of all people... A Harvard educated genius...
Yes, I noticed Kaposi's gave a date of later this year but GBM had no date. Let the speculation begin... Shorts will say data is bad and they won't be giving update. Longs will say no date means around ASCO. My guess is something will be coming soon!
From the latest PR:
Complete enrollment in the ongoing pivotal global Phase 3 clinical trial of aldoxorubicin as a second-line treatment for STS in the first quarter of 2016, with PFS data announced in second half of 2016
Report further results from ongoing Phase 2 clinical trial of aldoxorubicin in patients with unresectable GBM
Report further results from ongoing Phase 2 clinical trial of aldoxorubicin for the treatment of KS in HIV-infected patients by year end-2015
Complete enrollment in the ongoing Phase 1b clinical trial with a combination of aldoxorubicin and ifosfamide/mesna as first-line treatment for advanced sarcomas in the second half of 2015
Complete enrollment in the ongoing Phase 1b clinical trial with a combination of aldoxorubicin and gemcitabine in metastatic solid tumors in the second half of 2015
Complete enrollment in the ongoing Phase 2b clinical trial of aldoxorubicin in relapsed/refractory small cell lung cancer in the first quarter of 2016, with PFS data expected by the second half of 2016
Announce 1-2 new oncology pipeline drug candidates, which utilize novel linker technologies that couple chemotherapeutic agents and proteins either inside the body or externally, and then concentrate drug in tumors, in 2015 or early 2016
It will be interesting to see where GILD goes in the next 2 months. I do think it is due for run. They have so much cash, they just need to get it deployed with the right acquisitions.
I think everyone knows now ABBV will get at most 10% of the market. GILD needs to now go out and spend the money they are making wisely on more pipeline. Then the growth can continue. I think in the next 2 months this should go to about $130. That is at least my guess.
This has been my most resilient bio to this recent correction. That was after a nice run up nonetheless. Good luck, May approval coming!
Likely has multiple alias' and talks to himself like the other genius' who spend hours per day telling us to sell out of the goodness of their heart... Probably never has made a losing trade either...
I have mixed feelings about the dividend. I wish they would just use the money they will make over the next couple years to purchase more pipeline. I think some purchases of small and micro cap cancer/pharma companies would be prudent. A lot of interesting stuff going on in this area and they have the know how to pick the right ones and get their products to market. And yes that was a HUGE beat!
briskitt44 has a thing against BDCs. He is always on FSC bad mouthing them to. Yet he owns no shares... Why would anyone spend so much time bad mouthing stocks they don't own? He sounds like he really knows things, so how does he have so much time on his hands to help out the "idiots" who bought PSEC and FSC by telling them to sell? Boy, reminds me of Slick- always trying to "help" out.